Desfesoterodine

Desfesoterodine is a medication used in the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency. It is a selective muscarinic receptor antagonist, which works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination.
Mechanism of Action[edit]
Desfesoterodine is the active metabolite of fesoterodine, which is a prodrug. Once administered, fesoterodine is rapidly hydrolyzed by nonspecific esterases to its active form, desfesoterodine. Desfesoterodine exerts its effects by inhibiting the muscarinic receptors in the bladder, reducing bladder muscle contractions and increasing bladder capacity.
Pharmacokinetics[edit]
Desfesoterodine is well absorbed after oral administration. It reaches peak plasma concentrations within a few hours. The drug is primarily metabolized in the liver and excreted in the urine. The half-life of desfesoterodine is approximately 7-8 hours, allowing for once-daily dosing.
Indications[edit]
Desfesoterodine is indicated for the treatment of overactive bladder with symptoms of urinary urgency, urinary frequency, and urge incontinence.
Side Effects[edit]
Common side effects of desfesoterodine include:
Less common but more serious side effects may include:
Contraindications[edit]
Desfesoterodine is contraindicated in patients with:
- Urinary retention
- Gastric retention
- Uncontrolled narrow-angle glaucoma
- Known hypersensitivity to the drug or its components
Dosage and Administration[edit]
Desfesoterodine is typically administered once daily, with or without food. The dosage may be adjusted based on the patient's response and tolerability.
Interactions[edit]
Desfesoterodine may interact with other medications, including:
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
-
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
